2 Firms To Rep BioXcel Investors In Suit Against AI Drugmaker
Levi & Korsinsky LLP and Grant & Eisenhofer PA will co-lead a proposed shareholder class action in Connecticut alleging AI-based drugmaker BioXcel Therapeutics Inc. hurt investors after announcing plans to investigate...To view the full article, register now.
Already a subscriber? Click here to view full article